LMVVX
Price
$33.33
Change
+$0.53 (+1.62%)
Updated
Jul 9 closing price
Net Assets
97.53M
SSGSX
Price
$52.88
Change
+$0.60 (+1.15%)
Updated
Jul 9 closing price
Net Assets
4.5B
Interact to see
Advertisement

LMVVX vs SSGSX

LMVVX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
LMVVX vs. SSGSX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVVX is a Buy and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.5B vs. LMVVX (97.5M). SSGSX pays higher dividends than LMVVX: SSGSX (0.51) vs LMVVX (0.10). LMVVX was incepted earlier than SSGSX: LMVVX (7 years) vs SSGSX (27 years). SSGSX (1.23) is less costly to investors than LMVVX (1.10). LMVVX is a more actively managed with annual turnover of: 77.00 vs. SSGSX (50.00). LMVVX has a lower initial minimum investment than SSGSX: LMVVX (0) vs SSGSX (2500). SSGSX annual gain was more profitable for investors over the last year : 15.78 vs. LMVVX (13.75). LMVVX return over 5 years is better than : 1.09 vs. SSGSX (-2.82).
LMVVXSSGSXLMVVX / SSGSX
Total Expense Ratio1.031.2384%
Annual Report Gross Expense Ratio1.101.2389%
Fund Existence7 years27 years-
Gain YTD15.24916.98490%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets97.5M4.5B2%
Annual Yield % from dividends0.100.5120%
Returns for 1 year13.7515.7887%
Returns for 3 years22.0012.48176%
Returns for 5 years1.09-2.82-39%
Returns for 10 yearsN/A40.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD6.510.10
+1.56%
Relmada Therapeutics
FOXA53.740.35
+0.66%
Fox Corp
HP32.75-0.25
-0.76%
Helmerich & Payne
TCX10.42-0.22
-2.07%
Tucows
GELS0.54-0.01
-2.66%
Gelteq Ltd